Pharmx Technologies Ltd (PHX)

Currency in AUD
0.088
0.000(0.00%)
Closed·
PHX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0860.088
52 wk Range
0.0840.200
Key Statistics
Bid/Ask
0.083 / 0.087
Prev. Close
0.088
Open
0.086
Day's Range
0.086-0.088
52 wk Range
0.084-0.2
Volume
232.77K
Average Volume (3m)
267.51K
1-Year Change
-29.6%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PHX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Pharmx Technologies Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Pharmx Technologies Ltd Earnings Call Summary for H2/2026

  • PharmX FY 2026 revenue rose 3% to AUD 7.7M; recurring revenue up 9%; EBITDA fell to AUD 1.1M from AUD 1.6M amid higher investment spending.
  • Marketplace commission revenue surged 73% YoY; company targets AUD 100M annualized GTV run rate within 12 months from AUD 4.7M monthly in July.
  • Operating expenses climbed to AUD 6.7M from AUD 6.0M, driven by Marketplace launch and Sigma Healthcare strategic partnership investments.
  • Shares dropped 4.76% to 10 cents, near 52-week low, as investors weigh growth momentum against tighter cash position of AUD 2.6M and profitability timeline.
  • CEO Culver expects FY 2027 revenue and margin expansion; new streams include advertising, demand planning; AUD 1.2M R&D tax refund anticipated H1.
Last Updated: 2026-08-26, 09:08 p/m
Read Full Transcript

Earnings

Latest Release
Aug 26, 2026
EPS / Forecast
-- / --
Revenue / Forecast
3.73M / --
EPS Revisions
Last 90 days

PHX Income Statement

Compare PHX to Peers and Sector

Metrics to compare
PHX
Peers
Sector
Relationship
P/E Ratio
−32.1x6.3x12.1x
PEG Ratio
0.060.060.01
Price/Book
2.5x2.6x2.4x
Price / LTM Sales
7.7x2.9x2.2x
Upside (Analyst Target)
-48.1%36.0%
Fair Value Upside
Unlock12.8%6.2%Unlock

Pharmx Technologies Limited, together with its subsidiaries, engages in the technology and software development business in Australia and New Zealand. It offers Pharmx Gateway, an electronic ordering and invoicing solution; Pharmx Marketplace, an e-commerce ordering platform; and Pharmx Analytics, a solution that provides insights for suppliers and buyers. The company was formerly known as Corum Group Limited and changed its name to Pharmx Technologies Limited in October 2023. Pharmx Technologies Limited was incorporated in 1950 and is based in Sydney, Australia.

Employees
109
Market
Australia

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
202.85M30.76%17.85M
Public Companies & Retail Investors
456.61M69.24%40.18M
Total
659.46M100.00%58.03M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Lujeta Pty Ltd.15.14%99,863,5028,788
Cw Retail Holdings Pty Ltd9.09%59,950,6795,276

FAQ

What Is the Pharmx Tech (PHX) Stock Price Today?

The Pharmx Tech stock price today is 0.088 AUD.

What Stock Exchange Does Pharmx Tech Trade On?

Pharmx Tech is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Pharmx Tech?

The stock symbol for Pharmx Tech is "PHX."

What Is the Pharmx Tech Market Cap?

As of today, Pharmx Tech market cap is 58.620M AUD.

What Is Pharmx Tech's Earnings Per Share (TTM)?

The Pharmx Tech EPS (TTM) is -0.003.

When Is the Next Pharmx Tech Earnings Date?

Pharmx Tech will release its next earnings report on Dec 02, 2026.

From a Technical Analysis Perspective, Is PHX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Pharmx Tech Stock Split?

Pharmx Tech has split 2 times.

How Many Employees Does Pharmx Tech Have?

Pharmx Tech has 109 employees.

What is the current trading status of Pharmx Tech (PHX)?

As of Sep 04, 2026, Pharmx Tech (PHX) is trading at a price of 0.088 AUD, with a previous close of 0.088 AUD. The stock has fluctuated within a day range of 0.086 AUD to 0.088 AUD, while its 52-week range spans from 0.084 AUD to 0.200 AUD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.